First Trust Advisors’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
First Trust Advisors's PCVX Position: Q3 2026 in Review
First Trust Advisors opened a new position in Vaxcyte (PCVX) in Q3 2026: 4,273 shares worth $243K. The stake represents ﹤0.01% of the portfolio and ranks #2579 among its holdings. This is a return to the name: First Trust Advisors previously reported a position in PCVX as recently as Q4 2024.
First Trust Advisors first reported a position in PCVX in Q4 2022 and has held it in 10 quarters since. The position peaked at $13.5M in Q3 2024. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- First Trust Advisors held 4,273 shares of Vaxcyte worth $243K as of Q3 2026.
- Vaxcyte was a new First Trust Advisors position in Q3 2026.
- Vaxcyte made up ﹤0.01% of First Trust Advisors's portfolio in Q3 2026, its #2579 holding.
- First Trust Advisors first reported a position in Vaxcyte in Q4 2022 and has held it in 10 quarters since.
- First Trust Advisors's Vaxcyte position peaked at $13.5M in Q3 2024.
- 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on First Trust Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.